Drug intelligence / Profile preview

microRNA-873 mimic

Development stage
Preclinical
Modality
MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

microRNA-873 mimic is a synthetic, double-stranded RNA oligonucleotide designed to replicate the biological activity of endogenous miR-873, a microRNA that functions as a tumor suppressor in various malignancies. In colorectal cancer (CRC), miR-873 expression is frequently downregulated, which correlates with advanced disease stages and poor patient survival. The miR-873 mimic acts by binding to the 3' untranslated regions (UTRs) of its target messenger RNAs, specifically **TNF receptor-associated factor 5 (TRAF5)** and **TGF-β activated kinase 1 (MAP3K7) binding protein 1 (TAB1)**. By downregulating these targets, the mimic inhibits the activation of the **NF-κB signaling pathway**, thereby suppressing cancer cell proliferation, migration, and progression. It is currently utilized in preclinical research to explore therapeutic strategies for restoring regulatory control in miR-873-deficient tumors.

Other names
miR-873 mimicmiR873 mimicmiR 873 mimichsa-miR-873 mimichsa-miR873 mimichsa-miR 873 mimicmicroRNA-873-5p mimicmicroRNA873-5p mimicmicroRNA 873-5p mimic
02

Targets

E3 ligase (E3 ubiquitin ligases)

Beyond the preview

Go deeper on microRNA-873 mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA-873 mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call